← back to search
Eric Briggs
University of Utah
· US
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Vascular Anomalies and Treatments, Tracheal and airway disorders, Cervical Cancer and HPV Research, and Virus-based gene therapy research.
h-index
4
citations
117
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?
Genetics in Medicine
2019
cited by
58
position: middle
doi
Characterization of a family mutation in the 5’ untranslated region of the endoglin gene causative of hereditary hemorrhagic telangiectasia
Journal of Human Genetics
2019
cited by
14
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Jamie McDonald
· University of Utah
2
papers (2019–2019)
Pınar Bayrak‐Toydemir
· Sanford Health
2
papers (2019–2019)
Whitney Wooderchak‐Donahue
· University of Utah
2
papers (2019–2019)
Emma Bedoukian
· California University of Pennsylvania
1
papers (2019–2019)
Mark S. Chesnutt
· Society of Interventional Radiology
1
papers (2019–2019)
Kate Henderson
· Mississippi State University
1
papers (2019–2019)
James R. Treat
· California University of Pennsylvania
1
papers (2019–2019)
Wei Shen
· Mayo Clinic
1
papers (2019–2019)
Gülsen Akay
· Baylor College of Medicine
1
papers (2019–2019)
David A. Stevenson
· Sir Ganga Ram Hospital
1
papers (2019–2019)
Gábor Marth
· University of Utah
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Jeffrey Pollak
· Weill Cornell Medicine
1
papers (2019–2019)
Matthew Velinder
· University of Utah
1
papers (2019–2019)
Joseph E. Jacher
· University of Michigan–Ann Arbor
1
papers (2019–2019)
Lı́dia Ruiz
· Centro de Investigaciones Biológicas Margarita Salas
1
papers (2019–2019)
—
·
1
papers (2019–2019)
Kevin J. Whitehead
· University of Utah
1
papers (2019–2019)
Andrew Farrell
· University of Utah
1
papers (2019–2019)
Brendan O’Fallon
· Intel (United States)
1
papers (2019–2019)